您当前的位置:
3-Methyladenine. ()
III类PI3K抑制剂,3-Methyladenine是 PI3K 的抑制剂。它通过抑制class III PI3K广泛作为自噬 (autophagy) 的抑制剂使用。
目录号: PC16216 纯度: ≥99%
CAS No. :5142-23-4
商品编号 规格 价格 会员价 是否有货 数量
PC16216-50mg 50mg ¥445.00 请登录
PC16216-100mg 100mg ¥665.00 请登录
PC16216-200mg 200mg ¥1150.00 请登录
PC16216-500mg 500mg ¥2320.00 请登录
PC16216-10mM (in 1mL DMSO) 10mM (in 1mL DMSO) ¥135.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
3-Methyladenine.
中文别名
6-氨基-3-甲基嘌呤;3-甲基腺嘌呤;3-Methyladenine 3-甲基腺嘌呤;3-甲基腺素;6-氨基-3-甲基嘌呤、3-甲基腺嘌呤;NSC66389 抑制剂;邻二氮杂菲;1,10-菲罗啉(无水);2,9-二甲基啉菲罗啉,新铜试剂;3-甲基-3H-嘌呤-6-胺;6-氨基-3-甲基嘌呤(3MA);细胞自噬抑制剂
英文名称
3-Methyladenine
英文别名
3-METHYLADENINE;3H-Purin-6-amine,3-methyl-;3-MA;3-Methyl-3H-purin-6-amine;3-Methyladenine (3-MA);3-methylpurin-6-amine;6-?Amino-?3-?methylpurine;3-MA,6-Amino-3-methylpurine;6-Amino-3-methylpurine;3-Methyl-6-aminopurine;N3-Methyladenine;NSC 66389;3H-Purin-6-amine, 3-methyl-;3-Methyl-3H-adenine;ADENINE, 3-METHYL-;3-METHYL-3H-PURIN-6-YLAMINE;3-Methyladenine autophagy inhibitor;3mea;4aia;3-methyl-Adenine;NSC66389;1p7m;4ai5;Autophagy Inhibitor, 3-MA;NCIOpen2_000270;SCHEMB
Cas No.
5142-23-4
分子式
C6H7N5
分子量
149.15
包装储存
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
生物活性

3-Methyladenine (3-MA) is a PI3K inhibitor. 3-Methyladenine is a widely used inhibitor of autophagy via its inhibitory effect on class III PI3K.

性状

Solid

IC50 & Target[1][2]

PtdIns3Kγ

60 μM (IC50, Cell Assay)

Vps34

25 μM (IC50, Cell Assay)

Autophagy

 

Mitophagy

 

Human Endogenous Metabolite

 

体外研究(In Vitro)

3-Methyladenine (0-10 mM; 0-48 hours) induces caspase-dependent cell death in HeLa cells in a time-and dose-dependent manner.
3-Methyladenine (5 mM; 24 hours) suppresses autophagy in HeLa cells under both glucose-free conditions and normal conditions.
3-Methyladenine (5 mM; 0-48 hours) suppresses conversion of LC3-I to LC3-II (autophagy markers) between 12hours and 48 hours, confirms the inhibitory effects on autophagy.
3-Methyladenine induces cell death is independent of autophagy inhibition.
3-Methyladenine significantly shortens the duration of nocodazole-induced-prometaphase arrest.
Note:
在体外细胞培养实验中,3-MA 常用的浓度为 0.5-10 mM,所以优先推荐直接称取本次实验所需粉末量,用培养基完全溶解,0.22 μm 过滤器过滤除菌之后使用。建议溶液现配现用,尽快用完。

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay

Cell Line: HeLa cells
Concentration: 0 mM, 2.5 mM or 5 mM, 10 mM
Incubation Time: 0 hour, 24 hours and 48 hours
Result: Decreased cell viability in a time-and dose-dependent manner, and was associated with caspase-3 activation.

Cell Autophagy Assay

Cell Line: HeLa cells
Concentration: 5 mM
Incubation Time: 24 hours
Result: Suppressed autophagy in HeLa cells under both glucose-free conditions and normal conditions.

Western Blot Analysis

Cell Line: HeLa cells
Concentration: 5 mM
Incubation Time: 0 hour, 12 hours, 24 hours and 48 hours
Result: Suppressed conversion of LC3-I to LC3-II between 12 hours and 48 hours.
体内研究(In Vivo)

3-Methyladenine (1.5?mg/100?g; intraperitoneal injection; 3-24?hours) treatment alleviates sodium taurocholate-induced severe acute pancreatitis (SAP) in rats at both 12 hours and 24?hours.
3-Methyladenine inhibits autophagy of pancreatic acinar cells in sodium taurocholate-tnduced SAP.
3-Methyladenine also shows inhibitory effects on PI3K/Akt signaling pathway and NF-κB signaling pathway in sodium taurocholate-induced SAP.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 10–12 weeks Specific pathogen free- (SPF-) grade healthy male Sprague-Dawley (SD) rats (250–290?g)
Dosage: 1.5?mg/100?g (1000 μM)
Administration: Intraperitoneal injection
Result: Alleviated Sodium Taurocholate-Induced SAP.
运输条件

Room temperature or refrigerated transportation.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
结构分类
参考文献
溶解度数据
体外研究: 

H2O : 5 mg/mL (33.52 mM; Need ultrasonic)

DMSO : 8.33 mg/mL (55.85 mM; Need ultrasonic)

配制储备溶液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 6.7047 mL 33.5233 mL 67.0466 mL
5 mM 1.3409 mL 6.7047 mL 13.4093 mL
10 mM 0.6705 mL 3.3523 mL 6.7047 mL
*

产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,建议在 6 个月内使用,-20°C 储存时,建议在 1 个月内使用。

体内研究:

建议根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都建议先按照 体外研究 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    建议依照次序添加每种溶剂: PBS

    Solubility: 4 mg/mL (26.82 mM); Clear solution; Need ultrasonic

*
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2